PUBLICATION · Jun 2025

The Journal of Clinical Investigation, Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model

PUBLICATION · Jun 2025 · PDF

Journal of Bone and Mineral Research, Infigratinib Low Dose Therapy Is an Effective Strategy to Treat Hypochondroplasia

PUBLICATION · May 2025 · PDF

Journal of the American College of Cardiology, Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - ESC-HF 2025 - Improvement in Serum TTR Levels in Wild-type or Variant Transthyretin Amyloid Cardiomyopathy

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - PNS 2025 - Low Transthyretin Is Associated With Severe Comorbidities

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis AG10 TTR - ESC-HF 2025 - Disease Progression Among Patients for ATTR-CM in a Real-world Setting

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - ESC-HF 2025 - Atrial Fibrillation-related Events in Patients with ATTR-CM in ATTRibute-CM

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - ESC-HF 2025 - Functional Capacity and Quality of Life in Variant ATTR-CM from ATTRibute-CM

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - ESC-HF 2025 - All-cause Mortality, Cardiovascular Hospitalization and NT-proBNP in Variant ATTR-CM from ATTRibute-CM

PRESENTATION · May 2025 · PDF

BBIO - Acoramidis TTR - ESC-HF 2025 - Time from First Recorded Clinical Manifestation to Diagnosis of Transthyretin Amyloid Cardiomyopathy: A Retrospective Cohort Study Using U.S. Claims Data